ContextVision taking a position on the growing mammography market
Three new Mammography contracts within 3 months’ time
Stockholm, Sweden - March28, 2013 –ContextVision, a leading provider of image enhancement, has just signed the third contract for mammography within three months’ time, leading the way within Mammography image enhancement.
Digital mammography is growing quickly on a global basis as many x-ray manufacturers develop into this segment. ContextVision’s image enhancement software brings significant value to mammography imaging as it adds the necessary performance to satisfy radiologists in their very demanding working situations.
- Mammography is complex and requires advanced image enhancement. We have both the required technology and the right know-how to support our customers, says Anita Tollstadius, CEO. This is unique, and highly appreciated by customers.
More and more of mammography screening programs are being discussed in several countries; other countries are just now introducing broader programs.
- There are huge challenges within this modality and ContextVision has successfully managed to support the mammography manufacturers with the best image enhancement available. Being able to provide first class solutions for all modalities, makes us an even more attractive partner for the multi-modality manufacturers, says Anita Tollstadius.
Since 1983, ContextVision has been a leading provider of image enhancement software to the global medical imaging industry, with the versatile GOP® technology at the core of all our imaging solutions. We play a key role in helping manufacturers by offering clinicians unparalleled diagnostic image quality, ultimately providing patients with better care.
ContextVision continues to offer the latest software and expertise within ultrasound, x-ray, magnetic resonance imaging, mammography, fluoroscopy and computed tomography. Our groundbreaking technology and lengthy expertise have granted us a pioneer position within
2D/3D/4D image enhancement across multiple modalities. For more information, please visit: